
Neuren Pharmaceuticals (NEU) is a biopharmaceutical company developing therapies for brain injury, neurodevelopmental and neurodegenerative disorders.
NEU has two key drug products comprising NNZ-2566 and NNZ-2591.
NEU has operations in New Zealand, Australia and the USA.